Tag:

NeuVax

Latest Headlines

Latest Headlines

Breast cancer-vaccine developer bags Teva Pharma, Dx deals to bolster PhIII program

FierceBiotech | December 7, 2012
The Oregon biotech revealed a pair of agreements focused on the company's therapeutic vaccine for breast cancer, a therapy in Phase III development, including a "signature" pact with the global group Teva Pharmaceutical Industries to commercialize the biotech's lead product in Israel.

Galena stock jumps with NeuVax patent

July 18, 2012 | By
Galena Bipharma's stock jumped a cool 35% when the company received a patent granting its breast cancer vaccine exclusivity until 2028.

Late-stage Galena vax offers hope for breast cancer patients

January 25, 2012 | By
Oregon's Galena Biopharma ($GALE) is edging closer to a submission for NeuVax after the initiation of a Phase III trial for its vaccine to prevent HER2 1+ and 2+ breast cancer recurrence in the...
Related Tags
Press Releases
  • Oculus Innovative Sciences Receives FDA Clearance for Novel Atopic Dermatitis Dermatology Product
  • Augmenix Announces Publication of SpaceOAR System Clinical Trial Results in Leading Radiation Oncology Journal
  • Navidea Reports Manocept Study Results in Rheumatoid Arthritis Presented at EULAR 2015
  • Beckman Coulter Diagnostics Obtains CE Marks for New HCV RNA and HIV-1 Assays on DxN VERIS Molecular Diagnostics System
  • Medtronic Initiates U.S. Launch of Fortrex(TM) PTA Balloon
  • More Press Releases
Sponsored Links